Our Work

HBHI is pleased to announce our five pilot grant awardees for our 2023 cohort.

The emergence and increasing use of artificial intelligence and machine learning (AI/ML) in healthcare practice and delivery is being greeted with both optimism and caution. We focus on the nexus of AI/ML and racial disparities in healthcare: an issue that must be addressed if the promise of AI to improve patient care and health outcomes is to be realized in an equitable manner for all populations.

There is much debate about the effects of pharmaceutical direct to consumer advertising (DTCA) on health care use. In this paper, we inform this debate by examining the effects of DTCA on office visits, as well as treatment courses resulting from those visits, for five common chronic conditions (hypertension, hyperlipidemia, diabetes, depression, and osteoporosis). In particular, we examine whether office visits result in use of drug therapy and/or continued office visits over time.